Rekvina Laboratories Limited (BOM:526075)
India · Delayed Price · Currency is INR 54.90
+1.07 (1.99%)
At close: Sep 7, 2026
Rekvina Laboratories Market Cap
Rekvina Laboratories has a market cap or net worth of 324.49 million as of September 4, 2026. Its market cap has increased by 1,096.22% in one year.
Market Cap
324.49M
Enterprise Value
339.06M
Revenue
19.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
54.90
ChartMarket Cap Chart
Since July 26, 2013, Rekvina Laboratories's market cap has decreased from 443.60M to 324.49M, a decrease of -26.85%. That is a compound annual growth rate of -2.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 324.49M | 1,096.22% |
| Dec 13, 2021 | 27.13M | 4.65% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ANG Lifesciences India | 445.16M |
| Rajnish Wellness | 406.14M |
| Vista Pharmaceuticals | 386.55M |
| Panjon | 384.49M |
| Sandu Pharmaceuticals | 369.24M |
| Murae Organisor | 353.20M |
| Cian Healthcare | 334.75M |
| JFL Life Sciences | 325.00M |